#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11910	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2149	546.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1436	1436	C	678	C	654	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11910	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2149	546.7	0	HET	.	.	.	C1200T	.	1200	1200	C	1452	1452	C	635	C,T	483,132	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21828	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3621	597.9	0	.	n	.	0	T695C	SNP	695	695	T	1068	1068	C	607	C	595	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21828	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3621	597.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1710	1710	A	697	A	675	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21828	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3621	597.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2344	2344	C	681	C	664	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21828	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3621	597.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2418	2418	A	730	A	709	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21828	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3621	597.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2970	2970	C	632	C	611	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	V36A	NONSYN	106	108	GTG	398	400	GCG	138;137;140	G;C;G	128;128;129	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	440	442	CGG	147;144;143	C;G;G	141;137;135	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	S68L	NONSYN	202	204	TCG	494	496	TTG	132;129;128	T,G;T;G	117,1;124;122	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	A90V	NONSYN	268	270	GCG	560	562	GTT	125;124;124	G;T,C,G;T,G	122;117,1,1;120,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	I105V	NONSYN	313	315	ATT	605	607	GTT	128;128;129	G;T;T	125;122;126	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	N125T	NONSYN	373	375	AAT	665	667	ACC	134;131;133	A;C;C	125;126;127	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	R135C	NONSYN	403	405	CGT	695	697	TGT	137;138;137	T;G;T	128;134;127	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	K151E	NONSYN	451	453	AAA	743	745	GAA	111;114;113	G;A;A	110;111;111	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	T152N	NONSYN	454	456	ACC	746	748	AAC	112;111;112	A;A;C	111;110;111	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	A172T	NONSYN	514	516	GCG	806	808	ACA	96;99;98	A;C;A	96;99;96	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	A175E	NONSYN	523	525	GCG	815	817	GAA	91;93;95	G;A;A	91;93;94	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	E176T	NONSYN	526	528	GAA	818	820	ACC	97;99;100	A;C;C	94;99;100	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	I178V	NONSYN	532	534	ATC	824	826	GTC	100;98;96	G;T;C	100;98;95	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	I188T	NONSYN	562	564	ATA	854	856	ACG	97;95;94	A;C;G	92;92;92	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	P200N	NONSYN	598	600	CCC	890	892	AAC	106;106;106	A;A;C	103;102;104	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	F220L	NONSYN	658	660	TTT	950	952	TTG	138;132;130	T;T;G,A	128;121;119,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1007	1009	ACC	120;120;122	A,G,C;C;C,G,A	113,1,1;117;115,2,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1010	1012	GAC	123;123;124	G;A,C;C	118;111,1;120	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1019	1021	GCG	122;120;119	G;C,G;G	120;89,1;114	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1055	1057	GCT	97;97;95	G,A;C;T,C	90,1;93;84,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1246	folP	858	858	91.61	folP.l15.c4.ctg.1	1489	83.1	1	SNP	p	R230S	1	.	.	688	690	AGC	980	982	AGC	148;148;147	A;G;C	138;140;136	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4214	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3280	127.1	1	SNP	p	S91F	0	.	.	271	273	TCC	504	506	TCC	145;145;146	T;C;C	138;139;141	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4214	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3280	127.1	1	SNP	p	D95G	0	.	.	283	285	GAC	516	518	GAC	140;139;138	G;A;C	134;133;135	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4214	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3280	127.1	1	SNP	p	D95N	0	.	.	283	285	GAC	516	518	GAC	140;139;138	G;A;C	134;133;135	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1344	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1290	103.1	1	SNP	p	G45D	1	.	.	133	135	GAC	445	447	GAC	179;177;177	G;A;C	175;169;173	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	742	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1068	68.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	128.1	1	SNP	p	D86N	0	.	.	256	258	GAC	589	591	GAC	142;142;144	G;A;C	138;135;142	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	128.1	1	SNP	p	S87I	0	.	.	259	261	AGT	592	594	AGT	143;143;143	A;G;T	139;141;136	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	128.1	1	SNP	p	S87R	0	.	.	259	261	AGT	592	594	AGT	143;143;143	A;G;T	139;141;136	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	128.1	1	SNP	p	S87W	0	.	.	259	261	AGT	592	594	AGT	143;143;143	A;G;T	139;141;136	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	128.1	1	SNP	p	S88P	0	.	.	262	264	TCC	595	597	TCC	143;143;140	T;C;C	140;138;138	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3282	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2592	125.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1475	1477	GGC	152;151;148	G;G;C	149;148;143	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1273	1275	GCC	182;181;182	G;C;C,G	170;172;171,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1276	1278	ATG	185;185;188	A;T;G	173;174;176	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1288	1290	ACC	195;194;195	A;C;C	179;184;183	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1288	1290	ACC	195;194;195	A;C;C	179;184;183	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1789	1791	ACC	159;158;159	A;C;C	148;149;150	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1843	1845	GCG	143;145;147	G;C;G	139;139;144	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1843	1845	GCG	143;145;147	G;C;G	139;139;144	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1966	1968	GGT	138;138;136	G;G;T	130;128;124	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1975	1977	AGC	125;123;121	A;G;C	118;115;114	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2493	127.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1993	1995	CCG	100;103;105	C,G;C,G;G,C	88,6;89,4;91,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4544	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3050	148.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1569	1571	CTG	165;161;161	C;T;G	148;146;144	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1866	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1933	95.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	609	609	C	107	C	99	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2118	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1604	130.8	0	.	p	.	0	E41K	NONSYN	121	123	GAA	413	415	AAA	167;168;170	A;A;A	162;163;165	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2118	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1604	130.8	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	923	923	T	183	T	174	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2118	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1604	130.8	1	SNP	p	G120K	0	.	.	358	360	GGT	650	652	GGT	165;163;162	G;G;T,G	157;159;147,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2118	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1604	130.8	1	SNP	p	A121N	0	.	.	361	363	GCC	653	655	GCC	163;163;164	G;C,T;C	157;155,1;158	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2118	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1604	130.8	1	SNP	p	A121D	0	.	.	361	363	GCC	653	655	GCC	163;163;164	G;C,T;C	157;155,1;158	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	8050	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4995	160.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2062	2064	CAT	190;188;187	C;A;T	184;182;180	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	944	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1004	93.0	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	170;174;176	A;T;G	166;168;172	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
